Bellone, G <br/><br/>
Tumor-associated transforming growth factor-beta and interleukin-10 contribute to a systemic Th2 immune phenotype in pancreatic carcinoma patients.  [electronic resource] 

 -  The American journal of pathology  Aug 1999 
 - 537-47 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0002-9440 
<br/><br/><label>Standard No.: </label>10.1016/s0002-9440(10)65149-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--immunology<br/>Aged<br/>Antibodies, Monoclonal<br/>Culture Media, Conditioned--pharmacology<br/>Dose-Response Relationship, Drug<br/>Female<br/>Humans<br/>Immunophenotyping<br/>Interferon-gamma--antagonists & inhibitors<br/>Interleukin-10--biosynthesis<br/>Interleukin-12--antagonists & inhibitors<br/>Killer Cells, Lymphokine-Activated--immunology<br/>Male<br/>Middle Aged<br/>Pancreatic Ducts--pathology<br/>Pancreatic Neoplasms--immunology<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>T-Lymphocytes--immunology<br/>Th1 Cells--immunology<br/>Th2 Cells--immunology<br/>Transforming Growth Factor beta--biosynthesis<br/>Tumor Cells, Cultured